Apogee Therapeutics (NASDAQ:APGE) Reaches New 12-Month High

Apogee Therapeutics (NASDAQ:APGE) Reaches New 12-Month High at $23.16

Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) shares reached a new 52-week high on Wednesday . The company traded as high as $23.16 and last traded at $23.07, with a volume of 138737 shares traded. The stock had previously closed at $22.22. Wall Street Analyst Weigh In APGE has been the subject of a […]

Related Keywords

Stifel Nicolaus , Nimishp Shah , Nasdaq , Securities Exchange Commission , Jefferies Financial Group , Apogee Therapeutics Inc , Apogee Therapeutics , Get Free Report , Financial Group , Director Nimish , Exchange Commission , Apogee Therapeutics Daily , Nasdaq Apge , Aapge , Medical , Stocks , Technicals ,

© 2025 Vimarsana